GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Szymon@lemmy.caEnglish
    5·
    1 year ago

    If you can keep someone from dying by being dependent on only your medication, you’ve created a customer for life rather than one who died and didn’t give you all their money to live another day.